Physician profile
Crystal B Chen
NPI 1821581372
$1,874.71
in general payments reported to CMS, 2019-2025
19 companies · $330 in 2025
The $330 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $70.18 · 2022: $322 · 2023: $798 · 2024: $355 · 2025: $330.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,177 · Education: $306.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,177.07 |
| Education | $305.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $388.61 | 2021-2024 | Thoratec Heartmate 3 Lvas Implant Kit, Navitor, Quadra Assura |
| Astrazeneca Pharmaceuticals LP | $288.48 | 2022-2024 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $171.78 | 2021-2024 | Lifevest |
| Merck Sharp & Dohme LLC | $164.75 | 2022-2025 | Verquvo, Capvaxive |
| Actelion Pharmaceuticals US, INC. | $158.16 | 2023-2025 | Uptravi, Opsumit |
| Novartis Pharmaceuticals Corporation | $144.87 | 2024-2025 | |
| Boston Scientific Corporation | $114.89 | 2021-2025 | Watchman Flx |
| Pfizer INC. | $85.62 | 2023-2025 | |
| Amgen INC. | $83.99 | 2022-2025 | Repatha, Repatha |
| Kestra Medical Technology Services, INC. | $76.60 | 2024-2025 | Assure Wcd |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.94 | 2023 | Jardiance |
| Lantheus Medical Imaging, INC. | $24.89 | 2023 | Definity |
| Biotronik INC. | $24.19 | 2023 | Biomonitor |
| Kiniksa Pharmaceuticals International, Plc | $23.47 | 2024 | Arcalyst |
| Janssen Pharmaceuticals, INC | $22.37 | 2024 | Xarelto |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $19.69 | 2022 | |
| Alnylam Pharmaceuticals INC. | $18.43 | 2025 | Onpattro |
| Bayer Healthcare Pharmaceuticals INC. | $17.00 | 2025 | |
| Medtronic, INC. | $12.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Crystal Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.